Clik here to view.
Angiotech excited by Cook stent data for PVD
Angiotech Pharmaceuticals’ (TSX:ANP; NASDAQ:ANPI) licensee Cook Medical presented one-year data at a medical conference that confirms sustained clinical outcomes with Cook’s drug-eluting peripheral...
View ArticleClik here to view.
Ontario fund invests $1 million in Interface Biologics
The Ontario Government’s Investment Accelerator Fund-Life Sciences (IAF-LS), which helps accelerate the growth of life sciences companies in Ontario, has invested $1 million in closely held Interface...
View ArticleClik here to view.
Interface, Q3 in Kinesyx development pact
Closely-held Interface Biologics of Toronto and Q3 Medical Devices have signed a joint development and commercialization agreement to combine Interface’s Kinesyx bioactive oligomers with the balloon...
View ArticleClik here to view.
CytoTools awaiting India clearance for DermaPro
Mark-Andre Freyberg CytoTools AG (DE000A0KFRJ1/T5O) of Germany and its Indian marketing partner, Centaur Pharmaceuticals, expect to receive regulatory clearance in the current quarter in India for lead...
View Article
